Los Angeles Capital Management LLC Sells 273,114 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Los Angeles Capital Management LLC reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 96.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,890 shares of the pharmacy operator’s stock after selling 273,114 shares during the period. Los Angeles Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $215,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Fulton Bank N.A. increased its position in shares of Walgreens Boots Alliance by 0.5% during the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock worth $2,796,000 after acquiring an additional 523 shares in the last quarter. Insight Folios Inc boosted its stake in Walgreens Boots Alliance by 5.8% during the 4th quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after purchasing an additional 525 shares during the last quarter. Pinnacle Financial Partners Inc raised its stake in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock worth $310,000 after purchasing an additional 555 shares during the last quarter. Westpac Banking Corp lifted its holdings in shares of Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after purchasing an additional 560 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV boosted its position in shares of Walgreens Boots Alliance by 20.6% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 3,524 shares of the pharmacy operator’s stock valued at $92,000 after buying an additional 602 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 22.2 %

Shares of WBA stock opened at $12.19 on Friday. The stock has a market capitalization of $10.52 billion, a price-to-earnings ratio of -1.74, a PEG ratio of 0.98 and a beta of 0.78. The company’s fifty day simple moving average is $16.72 and its two-hundred day simple moving average is $20.33. Walgreens Boots Alliance, Inc. has a 1 year low of $11.68 and a 1 year high of $31.32. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter in the prior year, the firm posted $1.16 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 8.20%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction dated Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on WBA shares. UBS Group lowered their price target on Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Bank of America dropped their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Evercore ISI reduced their target price on Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating for the company in a report on Monday, June 3rd. Finally, Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $23.07.

View Our Latest Research Report on Walgreens Boots Alliance

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.